You’ve made it this far, why not follow ☝️Clinical pharmacist @tghcares & asst professor @usfcop. Tweeting about harm reduction & SUD. Opinions are my own.
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - The Lancet https://t.co/Bxpz92ZC6t
AAPP opposes the SAMHSA policy change to prohibit the use of federal funds for the purchase of “fentanyl test strips or any other substance test kits intended for use by people using drugs.” Test strips are an essential component of overdose prevention... https://t.co/58gLMiNsCM
Evaluation of Outcomes for Veterans With Opioid Use Disorder Managed by a Clinical Pharmacist Practitioner - Jackson - 2026 - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library https://t.co/zpPGxz6ztK
Among these? The most detailed report of neonatal opioid toxicity from breastfeeding ever published.
One small problem: It's pharmacologically impossible.
The official journal of the Canadian Paediatric Society has just acknowledged that more than 100 of its case reports are fabricated. Incredible reporting from @RetractionWatch: https://t.co/ErcnEw60S6
📰 New @TIME article “What Comes After Fentanyl? In a ‘Period of Hyper-change,’ a New Opioid Is Emerging”
“In general, the United States and Canada really bear the majority of nitazene consumption around the world,” @alexkrotulski says…. More ⬇️⬇️⬇️
https://t.co/0TGpnuIruq
The association between buprenorphine doses above 16 milligrams and treatment retention in a multi‐payer national sample in the United States, 2014 to 2021 - Stringfellow - Addiction - Wiley Online Library https://t.co/BecK7S78lL
#USF Health's Water Street location enables us to play a leading role in growing Tampa's medical and research district. @USFCOP's move into this facility will benefit our students and help us better serve the health care needs of our region and state. https://t.co/a3Rkj9eVlr
@alcohol_review “compared to naltrexone or topiramate, semaglutide was associated with a significantly lower risk of incident AUD diagnosis”…HR 0.25 (0.21-0.30) 👀👀
"These findings provide evidence of the potential benefit of semaglutide in alcohol use disorder in real-world populations and call for further randomised clinical trials."
https://t.co/GhARt41ZjB
Bills under consideration in FL, WV, & TN would make it easier to charge people who use drugs with a fictitious crime...exposing law enforcement officers to fentanyl. Our own @clairezagorski explores this development with @RyanMarino in @Salon. #WTFentanyl https://t.co/N5tvEQfWyd
Idaho has just repealed the law that permitted syringe services programs to operate in the state. AFAIK no state has *ever* gone backwards on this incredibly important issue. This is serious, folks. From CA to WV and many places in between, SSPs are under attack.
If you give a speech, in Congress, in support of pending legislation, your remarks will be scrutinized, especially as a celebrity. Those of us who work in this policy space in particular know how damaging stigma is to PWUD. 1/3